• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS HCG + BETA TEST SYSTEM; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS HCG + BETA TEST SYSTEM; SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN Back to Search Results
Catalog Number 03271749190
Device Problem Incorrect Or Inadequate Test Results (2456)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 06/10/2017
Event Type  malfunction  
Manufacturer Narrative
This event occurred in (b)(6).Unique identifier (udi)#: (b)(4).
 
Event Description
The customer complained of imprecise results for 4 patients tested for elecsys hcg + beta test system (hcg + b) on a cobas 6000 e 601 module when testing between serum samples and edta samples.Erroneous results were reported outside of the laboratory.Due to a history of false negative results, the customer confirms all negative hcg + b test results by performing a rapid card test.The rapid card test for all 4 patients was positive.When the patient samples were repeated using the serum samples the results were positive.When the edta samples were repeated the results were negative.The customer thinks there may be an interference in the samples.The negative results support the clinical picture for these patients.The customer provided data for 3 "cases." the data provided within the 3 "cases" is not clear.Clarification on the contents of the 3 cases has been requested but has not been provided."case 1" documents patient id (b)(6) with an hcg + b result from an edta sample of 0.100 miu/ml with a data flag."case 1" also documents that on (b)(46 2017 patient id (b)(6) (female (b)(6)) had an hcg + b result from an edta sample of 0.100 miu/ml with a data flag.The result from the serum sample was 91.05 miu/ml."case 2" documents that on (b)(6) 2017 patient id (b)(6) (female, (b)(6)) initial hcg + b result from an edta sample was 0.100 miu/ml with a data flag.The result from the serum sample was 31.68 miu/ml."case 2" also documents patient id (b)(6) with an hcg + b result from an edta sample of 0.100 miu/ml with a data flag."case 3" documents that on (b)(6) 2017 patient id (b)(6) (female, (b)(6)) initial hcg + b result from an edta sample was 0.100 miu/ml.The sample was repeated and the edta sample result was 0.100 miu/ml.There was no allegation that an adverse event occurred.The e601 module serial number was not provided.
 
Manufacturer Narrative
The ages initially provided in the report were obtained from the data provided by the customer.The customer has clarified that these ages are not correct.The ages for the affected patients were not provided.Age/date of birth was corrected.Relevant tests/lab data was corrected.The customer has clarified the description of events for 3 of the patient samples.(b)(6).
 
Manufacturer Narrative
The customer provided the results for the 4th patient sample.On (b)(6) 2017 patient 4 initial hcg + b result from an edta sample was 0.100 miu/ml with a data flag.The result from the serum sample was 30.67 miu/ml.
 
Manufacturer Narrative
The investigation received a serum and plasma aliquot for all 4 patients involved in this event.A specific root cause could not be identified.The plasma samples that were sent were either whole blood or extremely hemolytic.This sample material may not be valid for the hcg + b assay.Due to the quality of the plasma samples, the results generated do not indicate a product problem.A general reagent issue can be excluded.Further clarification of the issue is not possible with the available information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS HCG + BETA TEST SYSTEM
Type of Device
SYSTEM, TEST, HUMAN CHORIONIC GONADOTROPIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key6706690
MDR Text Key80056418
Report Number1823260-2017-01455
Device Sequence Number1
Product Code DHA
Combination Product (y/n)N
Reporter Country CodeTC
PMA/PMN Number
K003178
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 08/13/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/12/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2017
Device Catalogue Number03271749190
Device Lot Number15654201
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received06/20/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
Patient Age30 YR
-
-